Excellence Center
Seqens’Lab
The centre of excellence for developing a totally unique package of R&D services.
Sl
Seqens’Lab
Seqens’Lab offers a unique ecosystem, dedicated to our customers to accelerate their projects from discovery to production and sales. Discover our 34,000sqm science platform close to Paris!
As an R&D center that meets the highest standards, Seqens’Lab brings together the group’s key skills and expertise through :
- Its medical synthesis laboratory
- Its chemical process development laboratory
- Its crystallization process development laboratory
- Its cGMP Kilo-Lab
- Its solid state analysis laboratory including polymorph screening
- Its Analytical development laboratory
- Its expertise in Process Safety
- Its kinetic and thermodynamic simulation tools
- Its batch production capacities for pre-clinical and clinical studies
- Its Quality Control laboratory for clinical batch release and stability studies
- All this in a cGMP quality environment.
With Seqens’Lab, we aim to also facilitate collaboration amongst our teams in a modern and appealing location, designed for carrying out our customers’ projects more effectively and efficiently. Three main principles make up its definition:
- Create a dynamic ecosystem facilitating collaboration between Seqens teams, innovative SMEs and academic partners;
- Gather in one place multidisciplinary teams with the skills needed to complete our customers’ projects;
- Create an attractive and modern space, a reference point and a showcase for our customers.
Main characteristics
Markets
Markets
- Pharmaceuticals
- Specialty ingredients
- Cosmetics
Multi purpose pilot plant GMP
Multi purpose pilot plant GMP
- Reactors from 100 to 3,000 L
- Reactors covering a wide temperature range: from -80 to 200 °c
- Fully separated and controlled finishing areas
- Compliance: ANSM certificate
2000M2 of Laboratory Space
2000M2 of Laboratory Space
- 1 kilo-labs of 200 m²
- 1,000 m² of pilot units
- 12 m³ of reaction volume
Teams
Teams
- 140 employees with a dedicated team for each area of expertise:
- Clinical development phase of the API (early phase)
- API development phase (late phase)
- Synthesis intermediaries
- Analytical development (purity and impurity profiling)
- Solid State Characterization (structure elucidation, morphology and flow properties)
- Analytical method validation (in a GMP context) and quality control
Key Services
Analytical development and quality control
- Characterization of the API
- Development of analytical methods
- Validation of methods
- GMP testing
- GMP clinical batch release of manufactured product
- Product stability study according to ICH (International Harmonization Council)
Key Services
API’s development
- R&D on chemical processes
- Quality by Design Purification by crystallization
- Process Safety
- Design and characterization of the molecule in the solid state
- Provision of development reports
Key Services
Manufacture of Pharmaceutical active ingredients
- Batch scaling (up to 1 kg) for pre-clinical studies
- Manufacture of GMP pilot batches (from 1 to 80 kg) for clinical studies
- Provision of associated documentation